Daniel Brennan
Stock Analyst at TD Cowen
(4.84)
# 405
Out of 4,468 analysts
656
Total ratings
54.4%
Success rate
19.6%
Average return
Main Sectors:
Stocks Rated by Daniel Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PG The Procter & Gamble Company | Maintained: Hold | $150 | $151.41 | -0.93% | 1 | Jun 30, 2026 | |
| RVTY Revvity | Maintained: Buy | $120 | $113.76 | +5.49% | 24 | Jun 18, 2026 | |
| TEM Tempus AI | Reiterated: Buy | $68 | $60.27 | +12.83% | 19 | Jun 1, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $157 → $155 | $130.69 | +18.60% | 40 | May 27, 2026 | |
| GRAL GRAIL | Maintained: Buy | n/a | $69.11 | - | 4 | May 27, 2026 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | n/a | $523.44 | - | 39 | May 20, 2026 | |
| MDXH MDxHealth | Maintained: Buy | $7 → $1.5 | $0.4765 | +214.80% | 11 | May 14, 2026 | |
| ALMR Alamar Biosciences | Initiated Coverage: Buy | $30 | $25.94 | +15.65% | 1 | May 12, 2026 | |
| XGN Exagen | Maintained: Buy | $10 → $8 | $4.57 | +75.25% | 14 | May 11, 2026 | |
| PACB Pacific Biosciences of California | Reiterated: Buy | $3 | $1.68 | +78.57% | 25 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $135 → $127 | $167.98 | -24.40% | 18 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $10 | $13.62 | -26.58% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $31 | $18.30 | +69.40% | 8 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $53 → $40 | $40.10 | -0.25% | 25 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $280 | $279.32 | +0.24% | 25 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 → $25 | $39.01 | -35.91% | 32 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $373 → $385 | $379.29 | +1.51% | 27 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 → $4 | $4.33 | -7.62% | 17 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 | $21.19 | -0.90% | 15 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.01 | - | 15 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $21.99 | +36.43% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $135 → $55 | $67.51 | -18.53% | 19 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.35 | - | 14 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $118 → $140 | $188.68 | -25.80% | 43 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $9 | $10.32 | -12.79% | 24 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $14 | $15.16 | -7.65% | 21 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.73 | - | 12 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $270 → $240 | $197.93 | +21.25% | 32 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.62 | - | 12 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 | $5.99 | +16.96% | 21 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53 → $43 | $61.64 | -30.24% | 25 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $183 | $158.08 | +15.76% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.5 | $0.9129 | n/a | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $525 | $118.43 | n/a | 1 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $42.56 | n/a | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 → $62 | $6.04 | n/a | 3 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $99.24 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $390 → $465 | $230.69 | n/a | 7 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $880 → $1,139 | $1,308.43 | n/a | 12 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $224 → $275 | $207.04 | n/a | 4 | Apr 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $174 → $232 | $173.06 | n/a | 8 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $57.08 | n/a | 1 | Nov 26, 2013 |
The Procter & Gamble Company
Jun 30, 2026
Maintained: Hold
Price Target: $150
Current: $151.41
Upside: -0.93%
Revvity
Jun 18, 2026
Maintained: Buy
Price Target: $120
Current: $113.76
Upside: +5.49%
Tempus AI
Jun 1, 2026
Reiterated: Buy
Price Target: $68
Current: $60.27
Upside: +12.83%
Agilent Technologies
May 27, 2026
Reiterated: Buy
Price Target: $157 → $155
Current: $130.69
Upside: +18.60%
GRAIL
May 27, 2026
Maintained: Buy
Price Target: n/a
Current: $69.11
Upside: -
Thermo Fisher Scientific
May 20, 2026
Maintained: Buy
Price Target: n/a
Current: $523.44
Upside: -
MDxHealth
May 14, 2026
Maintained: Buy
Price Target: $7 → $1.5
Current: $0.4765
Upside: +214.80%
Alamar Biosciences
May 12, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $25.94
Upside: +15.65%
Exagen
May 11, 2026
Maintained: Buy
Price Target: $10 → $8
Current: $4.57
Upside: +75.25%
Pacific Biosciences of California
May 8, 2026
Reiterated: Buy
Price Target: $3
Current: $1.68
Upside: +78.57%
May 8, 2026
Rated: Buy
Price Target: $135 → $127
Current: $167.98
Upside: -24.40%
May 8, 2026
Maintained: Buy
Price Target: $11 → $10
Current: $13.62
Upside: -26.58%
May 8, 2026
Maintained: Buy
Price Target: $35 → $31
Current: $18.30
Upside: +69.40%
May 7, 2026
Rated: Hold
Price Target: $53 → $40
Current: $40.10
Upside: -0.25%
May 7, 2026
Rated: Buy
Price Target: $280
Current: $279.32
Upside: +0.24%
May 7, 2026
Maintained: Hold
Price Target: $19 → $25
Current: $39.01
Upside: -35.91%
May 6, 2026
Rated: Hold
Price Target: $373 → $385
Current: $379.29
Upside: +1.51%
May 6, 2026
Rated: Hold
Price Target: $7 → $4
Current: $4.33
Upside: -7.62%
May 6, 2026
Rated: Buy
Price Target: $21
Current: $21.19
Upside: -0.90%
May 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.01
Upside: -
May 5, 2026
Reiterated: Buy
Price Target: $30
Current: $21.99
Upside: +36.43%
May 5, 2026
Rated: Buy
Price Target: $135 → $55
Current: $67.51
Upside: -18.53%
May 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.35
Upside: -
Apr 30, 2026
Maintained: Hold
Price Target: $118 → $140
Current: $188.68
Upside: -25.80%
Apr 29, 2026
Maintained: Hold
Price Target: $10 → $9
Current: $10.32
Upside: -12.79%
Apr 28, 2026
Maintained: Buy
Price Target: $16 → $14
Current: $15.16
Upside: -7.65%
Apr 28, 2026
Maintained: Buy
Price Target: n/a
Current: $1.73
Upside: -
Apr 21, 2026
Rated: Buy
Price Target: $270 → $240
Current: $197.93
Upside: +21.25%
Feb 26, 2026
Maintained: Buy
Price Target: n/a
Current: $1.62
Upside: -
Feb 23, 2026
Maintained: Hold
Price Target: $7
Current: $5.99
Upside: +16.96%
Feb 13, 2026
Maintained: Hold
Price Target: $53 → $43
Current: $61.64
Upside: -30.24%
Jul 14, 2025
Maintained: Hold
Price Target: $183
Current: $158.08
Upside: +15.76%
May 6, 2025
Maintained: Buy
Price Target: $2.5
Current: $0.9129
Upside: n/a
Apr 27, 2023
Maintained: Buy
Price Target: $525
Current: $118.43
Upside: n/a
Apr 26, 2023
Maintained: Buy
Price Target: $45
Current: $42.56
Upside: n/a
Oct 15, 2021
Maintained: Buy
Price Target: $68 → $62
Current: $6.04
Upside: n/a
Oct 14, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $99.24
Upside: n/a
Aug 17, 2021
Maintained: Buy
Price Target: $390 → $465
Current: $230.69
Upside: n/a
May 7, 2021
Maintained: Sell
Price Target: $880 → $1,139
Current: $1,308.43
Upside: n/a
Apr 23, 2021
Maintained: Buy
Price Target: $224 → $275
Current: $207.04
Upside: n/a
Mar 1, 2021
Upgraded: Buy
Price Target: $174 → $232
Current: $173.06
Upside: n/a
Nov 26, 2013
Initiated Coverage: Buy
Price Target: $16
Current: $57.08
Upside: n/a